NCT05258786

Brief Summary

The study will observe the effect of antenatal biofeedback with transperineal and abdominal ultrasound applied by a pelvic floor physical therapist. The training will focus on pelvic floor training and maternal-coached pushing with ultrasound-based visual biofeedback. The investigators aim to assess maternal and neonatal obstetrical outcomes, urinary and fecal incontinence, and maternal psychological effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2022

Completed
10 days until next milestone

Study Start

First participant enrolled

February 18, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 28, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 28, 2024

Completed
Last Updated

January 31, 2024

Status Verified

January 1, 2024

Enrollment Period

1.9 years

First QC Date

February 8, 2022

Last Update Submit

January 30, 2024

Conditions

Keywords

pre-labor educationbiofeedbackultrasoundvaginal deliveryfear of childbirth

Outcome Measures

Primary Outcomes (1)

  • length of the second stage of labor

    measure by time (min/hour)

    up to 1 week after labor

Secondary Outcomes (4)

  • Mode of delivery

    up to 1 week after labor

  • Perineal tears

    up to 1 week after labor

  • Urinary and fecal incontinence

    up to 1 week after labor, and 2 month after labor.

  • Fear of birth questionnaire

    Baseline, a week later , 1 week after labor and two months after labor

Study Arms (3)

Intervention group

EXPERIMENTAL

Transabdominal ultrasound will be applied to optimize the training program of contracting pelvic floor muscles, aiming to decrease postpartum urinary and fecal incontinence. Transperineal ultrasound will be used for pre-labor-coached maternal pushing aiming to improve pushing during the second stage of labor, reduce operative deliveries, the incidence of perineal tears, and urinary and fecal incontinence.

Behavioral: Pre-labor ultrasound as a visual biofeedback device for maternal pushing education and pelvic floor training

Control group

NO INTERVENTION

A pelvic floor physiotherapist will provide the participants with a verbal explanation of how to contract pelvic floor muscles. without ultrasound.

Standard care

NO INTERVENTION

Questionnaires only at four timeline points - before delivery at recruitment (T0), a week later (T2), immediately postpartum (T3), and two months postpartum (T4)

Interventions

1. Ultrasound examination with the screen turned to the provider will assess the bladder movements at rest and during contraction of the pelvic floor and fetal head descent at rest and during pushing. 2. The provider will turn the screen to the patient and explain the anatomical landmarks: bladder, fetal head, birth canal direction. 3. A repeat of the first stage (1) with the screen turned to the patient: the biofeedback process. Bladder displacement will serve as a marker of pelvic floor contraction, and the delta in the progression angle will serve as a marker for effective pushing. 4. Finally, the provider will turn the screen again from the patient and repeat the first stage.

Intervention group

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • pregnant nullipara women with a low-risk pregnancy who are planned for vaginal delivery. The biofeedback will occur at 36-42 gestational weeks.

You may not qualify if:

  • an inability to fill questionaries due to communication issues or cesarean section performed due to major obstetrical events.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Noa Ben Ami

Ariel, 40700, Israel

Location

Study Officials

  • Noa Ben Ami, PhD

    Ariel University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcomes assessor will collect the data from the files without knowing the participant's groups (intervention/control/standard care)
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized controlled study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2022

First Posted

February 28, 2022

Study Start

February 18, 2022

Primary Completion

January 28, 2024

Study Completion

January 28, 2024

Last Updated

January 31, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations